Palo Alto Networks Inc – Highest Sales Growth in 9 Years

Palo Alto Networks Inc – Highest Sales Growth in 9 Years

Alif Fahmi

25 Sep 2026  |    9 views

Brief Overview

Palo Alto Networks delivered 4Q26 revenue and PATMI results that met expectations, with FY26 results at 101% of forecasts. The company achieved 34% year-on-year revenue growth, driven by platformisation and rising demand for AI-driven security solutions. Future growth is expected to be supported by platformisation, AI infrastructure buildout, and AI security adoption through various offerings.


Investment Positives

Strong organic growth represents a key investment highlight. The company achieved 4Q26 revenue growth of 34.4% year-on-year, marking the strongest performance since 1Q17. This robust growth was underpinned by two primary factors: platformisation, as customers consolidated security spending onto PANW’s platform to reduce costs and complexity, and rising demand for AI-driven security solutions such as Prisma AIRS and Cortex XSIAM (AgentiX) amid escalating AI-related threats.

Platformisation has driven significant upsell and cross-sell opportunities, supporting strong wallet share expansion and sustaining a net retention rate above 120%. The strategy has proven particularly effective among large enterprises, with deals exceeding US$10mn in NGS ARR growing 50% year-on-year in customer count terms. Top deal wins included telecommunications and payment platform companies. NGS refers to PANW’s newest AI- and ML-powered security offerings.

Inorganic growth from acquisitions provides additional momentum. PANW has integrated the financials of two recent acquisitions: CyberArk (Idira), which provides identity security for human, machine, and AI identities, and Chronosphere, which enhances observability across applications, infrastructure, and cloud workloads. Idira contributed US$336mn (10% of 4Q26 revenue) and US$1.5bn (13% of FY26 revenue on a pro forma basis), whilst accelerating 4Q bookings growth. The company also acquired Embrace and Console, though these were immaterial to FY27e guidance.


Challenges

The acquisitions, primarily CyberArk, required funding through a mix of cash and stock, resulting in increased debt levels and higher interest expense. The financing structure also increased shares outstanding in FY27e, which impacts dilution for existing shareholders.


Outlook

Future growth is expected to remain supported by platformisation and AI infrastructure buildout, with over 65% of NGS ARR from platformised customers and over 120% net retention rate supporting upsell and cross-sell activities. Rising AI capital expenditure is driving more infrastructure to secure and traffic to inspect. Additionally, AI security adoption through Prisma AIRS, Cortex, and CyberArk should benefit from autonomous agents increasing demand for governance, identity security and real-time cyber defence.

Recommendation & Target Price

Phillip Securities Research has downgraded its recommendation to NEUTRAL from ACCUMULATE, with a higher DCF-based target price of US$346 (previously US$320). The downgrade follows recent share price performance, with PANW rallying approximately 160% from its February low to an August peak of US$396.


Frequently Asked Questions

Q: What drove Palo Alto Networks' strong revenue performance in 4Q26?

A: Revenue growth of 34.4% year-on-year was driven by platformisation as customers consolidated security spending and rising demand for AI-driven security solutions amid escalating AI-related threats.

Q: How significant was the contribution from recent acquisitions?

A: CyberArk (Idira) contributed US$336mn (10% of 4Q26 revenue) and US$1.5bn (13% of FY26 revenue on a pro forma basis), whilst also accelerating 4Q bookings growth.

Q: What is the company's net retention rate performance?

A: The company maintains a net retention rate above 120%, supported by platformisation-driven upsell and cross-sell opportunities.

Q: How are large enterprise deals performing?

A: Large deals exceeding US$10mn in NGS ARR grew 50% year-on-year in customer count, with top wins including telecommunications and payment platform companies.

Q: What impact did acquisitions have on the company's financial structure?

A: The acquisitions, primarily CyberArk, increased debt levels and interest expense, and also increased shares outstanding in FY27e due to the mix of cash and stock funding.

Q: Why was the recommendation downgraded despite strong performance?

A: The recommendation was downgraded to NEUTRAL from ACCUMULATE following recent share price performance, with PANW rallying approximately 160% from its February low to an August peak.

Q: What are the key growth drivers for FY27e?

A: Growth should be supported by platformisation with over 65% of NGS ARR from platformised customers, AI infrastructure buildout, and AI security adoption through Prisma AIRS, Cortex, and CyberArk.

Q: What does NGS refer to in the context of PANW's offerings?

A: NGS refers to PANW's newest AI- and ML-powered security offerings.

Factsheets


This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.

 

Disclaimer
These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products.

Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance.

Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Related Articles

iX Biopharma Ltd – Gaining altitude with significant approvals

Brief Overview The US Secretary of Health and Human Services (HHS) has declared an Emergency...

  25 Sep 2026  |    15 views

Phillip Singapore Monthly: August 2026 – Trading at a Justified Premium

Brief Overview Singapore equities delivered another strong month in August, rising 2.3% for the fifth...

  25 Sep 2026  |    11 views

Q & M Dental Group Awaits Inorganic Growth Amid Challenging Operating Environment

Brief Overview Q & M Dental Group’s 1H26 results fell short of expectations, with revenue...

  25 Sep 2026  |    5 views

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com